Before prescribing PALYNZIQ®, please view and download the informational Risk Mitigation Materials below. These resources are being provided to ensure you are aware of the safety requirements and to reduce the risk of serious adverse reactions that patients may experience while taking PALYNZIQ. If you have questions, please contact BioMarin RareConnections at 1-877-597-6744 or biomarinrareconnections@innomar-strategies.com.